Sign Up to like & get
recommendations!
2
Published in 2022 at "ACS chemical biology"
DOI: 10.1021/acschembio.2c00479
Abstract: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the most important chemotherapeutics for non-small-cell lung cancer (NSCLC) therapy. The resistance to EGFR-TKIs is one of the biggest obstacles to NSCLC outcome. In this study,…
read more here.
Keywords:
cell;
non small;
small cell;
resistance ... See more keywords